Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Novel oxysterols have pro-osteogenic and anti-adipogenic effects in vitro and induce spinal fusion in vivo.

Johnson JS, Meliton V, Kim WK, Lee KB, Wang JC, Nguyen K, Yoo D, Jung ME, Atti E, Tetradis S, Pereira RC, Magyar C, Nargizyan T, Hahn TJ, Farouz F, Thies S, Parhami F.

J Cell Biochem. 2011 Jun;112(6):1673-84. doi: 10.1002/jcb.23082.

2.
3.

A novel osteogenic oxysterol compound for therapeutic development to promote bone growth: activation of hedgehog signaling and osteogenesis through smoothened binding.

Montgomery SR, Nargizyan T, Meliton V, Nachtergaele S, Rohatgi R, Stappenbeck F, Jung ME, Johnson JS, Aghdasi B, Tian H, Weintraub G, Inoue H, Atti E, Tetradis S, Pereira RC, Hokugo A, Alobaidaan R, Tan Y, Hahn TJ, Wang JC, Parhami F.

J Bone Miner Res. 2014 Aug;29(8):1872-85. doi: 10.1002/jbmr.2213.

4.

Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat.

Kha HT, Basseri B, Shouhed D, Richardson J, Tetradis S, Hahn TJ, Parhami F.

J Bone Miner Res. 2004 May;19(5):830-40. Epub 2004 Jan 12.

5.

Oxysterols enhance osteoblast differentiation in vitro and bone healing in vivo.

Aghaloo TL, Amantea CM, Cowan CM, Richardson JA, Wu BM, Parhami F, Tetradis S.

J Orthop Res. 2007 Nov;25(11):1488-97.

6.

A novel semisynthetic molecule icaritin stimulates osteogenic differentiation and inhibits adipogenesis of mesenchymal stem cells.

Sheng H, Rui XF, Sheng CJ, Li WJ, Cheng XY, Jhummon NP, Yu YC, Qu S, Zhang G, Qin L.

Int J Med Sci. 2013 Apr 23;10(6):782-9. doi: 10.7150/ijms.6084. Print 2013.

7.

Osteogenic oxysterol, 20(S)-hydroxycholesterol, induces notch target gene expression in bone marrow stromal cells.

Kim WK, Meliton V, Tetradis S, Weinmaster G, Hahn TJ, Carlson M, Nelson SF, Parhami F.

J Bone Miner Res. 2010 Apr;25(4):782-95. doi: 10.1359/jbmr.091024.

8.

Oxysterol-induced osteogenic differentiation of marrow stromal cells is regulated by Dkk-1 inhibitable and PI3-kinase mediated signaling.

Amantea CM, Kim WK, Meliton V, Tetradis S, Parhami F.

J Cell Biochem. 2008 Oct 1;105(2):424-36. doi: 10.1002/jcb.21840.

9.

Osteogenic oxysterols inhibit the adverse effects of oxidative stress on osteogenic differentiation of marrow stromal cells.

Shouhed D, Kha HT, Richardson JA, Amantea CM, Hahn TJ, Parhami F.

J Cell Biochem. 2005 Aug 15;95(6):1276-83.

PMID:
15880703
10.

Hedgehog signaling and osteogenic differentiation in multipotent bone marrow stromal cells are inhibited by oxidative stress.

Kim WK, Meliton V, Bourquard N, Hahn TJ, Parhami F.

J Cell Biochem. 2010 Dec 1;111(5):1199-209. doi: 10.1002/jcb.22846.

PMID:
20717924
11.
12.

PDGF receptor beta is a potent regulator of mesenchymal stromal cell function.

Tokunaga A, Oya T, Ishii Y, Motomura H, Nakamura C, Ishizawa S, Fujimori T, Nabeshima Y, Umezawa A, Kanamori M, Kimura T, Sasahara M.

J Bone Miner Res. 2008 Sep;23(9):1519-28. doi: 10.1359/jbmr.080409.

13.

Mitochondrial function contributes to oxysterol-induced osteogenic differentiation in mouse embryonic stem cells.

Kwon IK, Lee SC, Hwang YS, Heo JS.

Biochim Biophys Acta. 2015 Mar;1853(3):561-72. doi: 10.1016/j.bbamcr.2014.12.011. Epub 2014 Dec 16.

14.

Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway.

Richardson JA, Amantea CM, Kianmahd B, Tetradis S, Lieberman JR, Hahn TJ, Parhami F.

J Cell Biochem. 2007 Apr 1;100(5):1131-45.

PMID:
17031848
15.

Dose- and time-dependent effects of recombinant human bone morphogenetic protein-2 on the osteogenic and adipogenic potentials of alveolar bone-derived stromal cells.

Park JC, Kim JC, Kim BK, Cho KS, Im GI, Kim BS, Kim CS.

J Periodontal Res. 2012 Oct;47(5):645-54. doi: 10.1111/j.1600-0765.2012.01477.x. Epub 2012 Apr 4.

PMID:
22471302
16.
17.

Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow.

Georgiou KR, Scherer MA, Fan CM, Cool JC, King TJ, Foster BK, Xian CJ.

J Cell Physiol. 2012 Mar;227(3):909-18. doi: 10.1002/jcp.22807.

PMID:
21503894
18.

Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromal cells by alendronate via ERK and JNK activation.

Fu L, Tang T, Miao Y, Zhang S, Qu Z, Dai K.

Bone. 2008 Jul;43(1):40-7. doi: 10.1016/j.bone.2008.03.008. Epub 2008 Mar 29.

PMID:
18486585
19.

Bone morphogenetic protein receptor in the osteogenic differentiation of rat bone marrow stromal cells.

Wang A, Ding X, Sheng S, Yao Z.

Yonsei Med J. 2010 Sep;51(5):740-5. doi: 10.3349/ymj.2010.51.5.740.

Items per page

Supplemental Content

Write to the Help Desk